AstraZeneca launched a $1 billion “Ambition Zero Carbon” program that engages its entire value chain.
Author: Gail Dutton
AstraZeneca launched a $1 billion “Ambition Zero Carbon” program that engages its entire value chain. In-house, shifting to renewable energy sources is a big part of that plan. It calls for “decoupling energy consumption from business growth and substituting 100% of site energy consumption with renewables.” This includes installing solar panels on sites and transitioning heating and cooling to renewable energy sources. The company’s goal is to achieve net zero by 2045 and to use 100% renewable energy by the end of 2025. "At the end of 2021, 43% of our total energy consumption and 88% of our electricity were generated from a renewable energy source," White said. The company is also transitioning its approximately 17,000-vehicle fleet to fully electric to meet its goal of reducing emissions from its operations and fleet by 98% by 2026. Currently, about half the fleet is electric or hybrid. AstraZeneca is “on track to reduce greenhouse gas emissions from [its] global operations and fleet by 98% by 2026,” for Scope 1 and 2 – the direct and indirect emissions that result from the organization’s activities and those associated with purchased steam, heat, electricity or cooling, the company repod.